SCIESCOPUSQ2
Discover Oncology
SPRINGER, Germany
Discover Oncology is an academic journal published by SPRINGER (Germany). Identifiers: eISSN 2730-6011. Indexed in SCIE, SCOPUS. Metrics: JIF 2.9, CiteScore 1.9, SJR 0.880, SNIP 0.65. Subject areas: ENDOCRINOLOGY & METABOLISM, ONCOLOGY. tlooto lists 7,716 papers from this journal.
CiteScore
1.90
Scopus citation metric
SJR
0.880
SCImago rank
SNIP
0.65
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2730-6011
- Abbreviation
- DISCOV ONCOL
- Publisher
- SPRINGER
- Country
- Germany
Web of Science categories
SCIEENDOCRINOLOGY & METABOLISM, ONCOLOGY
Scopus ASJC categories
1306 Cancer Research1310 Endocrinology2712 Endocrinology2730 Oncology2807 Endocrine and Autonomic Systems
Keywords
Oncology | Endocrinology & Metabolism
Papers in this journal
Recent papers
- The emerging role of exosomal circRNAs in modulating apoptotic pathways and overcoming cancer therapy resistance
2026
- EGFL6 predicts unfavorable prognosis and serves as a potential indicator in esophageal carcinoma.
2026
- Exploring the immunomodulatory mechanisms of Astragalus membranaceus in esophageal cancer treatment through network pharmacology, molecular docking, and molecular dynamics simulation.
2026
- Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial).
2026
- Stereotactic body radiotherapy and other locoregional therapies for hepatocellular carcinoma in patients with cirrhosis: real-world treatment allocation, BCLC-stratified outcomes, and prognostic determinants.
2026
Most cited papers
- Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy
2025 · 365 citations
- The gold complex auranofin: new perspectives for cancer therapy
2021 · 119 citations
- AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis
2025 · 98 citations
- Hereditary ovarian cancer
2026 · 91 citations
- Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
2024 · 74 citations